CSRxP: Court Ruling Underscores Need For Congressional Action To Boost Prescription Drug Transparency
Jun 17, 2020
Lawmakers Must Step-in to Enact DTC List Price Disclosures, Additional… Read More
© 2026 CSRXP- All Rights Reserved
Press Release
CSRxP Launches “No Price Hikes” Campaign Urging Big Pharma To Suspend Summer Price Hikes
Jun 2, 2020
Drug Companies Must Forgo Mid-Year Price Increases While Millions of Americans… Read More
CSRXP: PUBLIC-PRIVATE PARTNERSHIP WILL HELP DELIVER RELIEF FROM BIG PHARMA’S INSULIN PRICE-GOUGING
May 27, 2020
Coalition Applauds Positive Step from the Administration to Lower Insulin… Read More
CSRxP: New Study Undercuts Bogus Net Price Refrain From Big Pharma
Mar 4, 2020
Brand Name Drug Companies Repeated List Price Hikes Lead to Higher Net Prices… Read More
CSRxP LAUNCHES SEVEN-FIGURE “PROMISE” CAMPAIGN URGING CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Feb 4, 2020
Comprehensive Effort Will Target D.C., In Addition To Nine Presidential &… Read More
CSRxP: SOTU 2020 OFFERS PRESIDENT UNIQUE MOMENT TO LEAD ON LOWERING Rx PRICES
Feb 3, 2020
Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable &… Read More
CSRXP APPLAUDS SENATE PASSAGE OF USMCA THAT PUTS AMERICAN PATIENTS FIRST
Jan 16, 2020
Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision… Read More
CSRXP: BIG PHARMA THUMBS ITS NOSE AT STRUGGLING AMERICANS WITH NEW YEAR PRICE HIKES
Jan 2, 2020
Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More… Read More
CSRXP: THE HOUSE HAS ACTED, TIME FOR SENATE TO DO ITS JOB
Dec 12, 2019
Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress… Read More
CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D
Dec 10, 2019
Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times… Read More
CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE
Nov 22, 2019
Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers… Read More
CSRxP: Policymakers Must Remove Big Pharma Carveout in USMCA
Oct 23, 2019
Washington Can Put Patients First By Amending Trade Provision That Would… Read More